SUNLENCA J Code: J1961

Sunlenca is a medication aligned to the HCPCS J Code: J1961 for billing, pricing, and reimbursement purposes in the United States. Classified under Misc., it is administered via the subcutaneous route and manufactured by Gilead Sciences.

According to CMS Drug Use Information: Lenacapavir is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Lenacapavir belongs to a class of drugs known as capsid inhibitors. It blocks the virus from growing and infecting more cells. This medication is also used to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Lenacapavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. There are 2 different brands used for treatment and prevention of HIV. Do not switch brands of lenacapavir without checking with your doctor.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.